Evidence map›Paper›PMID 25589647›Full record

ArticleJournal of virology2015

Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.

Kalani Halemano, Bradley S Barrett, Karl J Heilman, Thomas E Morrison, Mario L Santiago

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kalani HalemanoDepartment of Medicine, University of Colorado Denver, Aurora, Colorado, USA Department of Immunology and Microbiology, University of Colorado Denver, Aurora, Colorado, USA.
Bradley S BarrettDepartment of Medicine, University of Colorado Denver, Aurora, Colorado, USA.
Karl J HeilmanDepartment of Medicine, University of Colorado Denver, Aurora, Colorado, USA.
Thomas E MorrisonDepartment of Immunology and Microbiology, University of Colorado Denver, Aurora, Colorado, USA.
Mario L SantiagoDepartment of Medicine, University of Colorado Denver, Aurora, Colorado, USA Department of Immunology and Microbiology, University of Colorado Denver, Aurora, Colorado, USA mario.santiago@ucdenver.edu.
University of Colorado Denver · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Innate Restriction Factor Modulation of Retrovirus-specific Humoral ImmunityR01AI090795 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SANTIAGO, MARIO LUIS · 2010 to 2013
$2.8M
APOBEC3/Rfv3 and Immunoglobulin Somatic HypermutationR01AI116603 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SANTIAGO, MARIO LUIS · 2016 to 2020
$2.5M
Immunological impact of Tetherin retrovirus restrictionR21AI112418 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SANTIAGO, MARIO LUIS · 2014 to 2015
$427k
NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI090795NIAID NIH HHS R01 AI116603NIAID NIH HHS R21 AI112418
6 · The paper itself

Abstract

Antiretroviral neutralizing antibody (NAb) responses are often evaluated in the absence of Fc-dependent immune effectors. In murine Friend retrovirus infection, Apobec3/Rfv3 promotes a potent polyclonal NAb response. Here, we show that the Apobec3/Rfv3-dependent NAb response correlated with virus-specific IgG2 titers and that the in vivo neutralization potency of Apobec3/Rfv3-resistant antisera was dependent on activating Fcγ receptors but not complement. The data strengthen retroviral vaccine strategies aimed at eliciting NAbs that activate specific Fcγ receptors.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralCytidine DeaminaseFriend murine leukemia virusImmunoglobulin Fc FragmentsImmunoglobulin GMice, Inbred C57BLAntibodies, NeutralizingAntibodies, ViralApobec3 protein, mouseCytidine DeaminaseImmunoglobulin Fc FragmentsImmunoglobulin G

Identifiers

PMID25589647
PMCPMC4403405
OpenAlexW1984980656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.